Delivery Order SPE2DB22D2206-SPE2DB25FKE10
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $7,128.81 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5 mL) with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on June 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order serves as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,210.48 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a completion date of September 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract represents procurement of pneumococcal vaccine supplies to support federal medical supply chain requirements, with performance conducted at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $27,354.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare immunization...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $13,145.43 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,244.30 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ML) under a firm fixed-price contract. The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive, non-set-aside procurement. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,444.40 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKE10Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,522.46 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a firm fixed price structure and an ultimate completion date of September 30, 2025. This non-set-aside award was issued on September 29, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used in federal medical procurement to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. The company's contract awards with DLA consistently demonstrate competitive positioning through open competition and firm fixed pricing arrangements across varying order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/29/25 |